Opioids Summary

Mechanism of Action

  • Activate mu-opioid receptors in CNS
  • Mimic endogenous opioid peptides
  • Analgesia, sedation, respiratory depression

Common Opioids

  • Codeine: Weak opioid, CYP2D6 metabolism
  • Tramadol: Dual mechanism, less respiratory depression
  • Morphine: Gold standard for severe pain
  • Fentanyl: Short-acting, procedural sedation

Contraindications

  • Respiratory depression
  • Acute asthma exacerbation
  • Head injury/raised ICP
  • Paralytic ileus risk

Cautions

  • Renal/hepatic impairment
  • Elderly/debilitated patients
  • Respiratory disease
  • Prostatic hyperplasia

Side Effects

  • Respiratory depression
  • Nausea/vomiting
  • Constipation
  • Sedation/confusion
  • Hypotension

Interactions

  • CNS depressants (alcohol, benzodiazepines)
  • MAOIs (avoid)
  • SSRIs/SNRIs (tramadol - serotonin syndrome)

Overdose

  • Triad: Coma, respiratory depression, miosis
  • Antidote: Naloxone
  • Supportive care essential

Opioid Analgesics

Comprehensive guide to opioid medications for pain management

Overview

Opioid analgesics are usually used to relieve moderate to severe pain particularly of visceral origin. Repeated use of opioid analgesics can result in tolerance and dependence, although this is less relevant in the acute clinical context. Opioid dependent patients may require much higher doses of opioids to control their pain.

Clinical Note: Always balance pain relief benefits against risks of dependence, side effects, and respiratory depression.

Mechanism of Action

Receptor Activation

  • Opioid analgesics mimic endogenous opioid peptides
  • Cause prolonged activation of opioid receptors
  • Primarily target mu(μ)-receptors in brain areas involved in nociception

Central Effects

  • Analgesia: Pain relief
  • Respiratory depression: Direct inhibition of respiratory centre
  • Euphoria & sedation: Mood alteration
  • Postural hypotension: Depression of vasomotor centre
  • Miosis: IIIrd nerve nucleus stimulation
  • Nausea/vomiting: Chemoreceptor trigger zone stimulation
  • Constipation: Decreased GI motility

Choice of Opioid

Codeine

  • Indication: Mild to moderate pain
  • Metabolism: Converted to morphine via CYP2D6
  • Equivalence: 240 mg codeine ≈ 30 mg morphine
  • Contraindications:
    • CYP2D6 ultra-rapid metabolisers
    • Children under 12 years
    • Post-tonsillectomy/adenoidectomy for sleep apnoea

Tramadol

  • Indication: Moderate to severe pain, neuropathic pain
  • Mechanism: Dual action - opioid + serotonergic/adrenergic
  • Advantages: Less respiratory depression, constipation, addiction potential
  • Risks: Psychiatric reactions, seizures

Morphine

  • Gold standard for severe pain comparison
  • Onset: Peak effect within minutes (IV)
  • Duration: 3-4 hours clinical effect
  • Effects: Analgesia + euphoria + mental detachment
  • Side effects: Frequent nausea and vomiting

Diamorphine & Fentanyl

  • Diamorphine:
    • Similar to morphine but transmucosal absorption
    • Useful in children (intranasal) and difficult IV access
  • Fentanyl:
    • Brief action (30-45 minutes)
    • Ideal for procedural sedation

Contraindications

Do not prescribe opioids to people who have:

Respiratory Conditions

  • Acute respiratory depression
  • Acute exacerbation of asthma
  • Risk of bronchoconstriction from histamine release

Neurological Conditions

  • Head injury
  • Raised intracranial pressure
  • Interference with pupillary responses
  • CO₂ retention risk

Gastrointestinal Conditions

  • Risk of paralytic ileus
  • Reduced gastric motility

Cautions

Prescribe opioids with caution in people with the following conditions (reduced doses often required):

Condition Rationale for Caution
Impaired respiratory function/asthma Increased risk of respiratory depression
Renal impairment Increased and prolonged effects
Hepatic impairment Sedation/constipation may precipitate encephalopathy
Prostatic hyperplasia Risk of urinary retention
Bowel disorders Reduced gastric motility exacerbates conditions
Biliary tract disease Risk of ureteric/biliary spasm
Convulsive disorders Avoid tramadol in uncontrolled epilepsy
Adrenocortical insufficiency/Hypothyroidism Reduced dose recommended
Elderly/debilitated patients Increased sensitivity, reduced dose required

Side Effects

Common to All Opioids

Gastrointestinal

  • Nausea and vomiting
  • Constipation
  • Urinary retention

Central Nervous System

  • Sedation
  • Respiratory depression
  • Confusion

Cardiovascular

  • Peripheral vasodilation
  • Hypotension
  • Arrhythmias

Tramadol-Specific Side Effects

  • Convulsions: High doses or with seizure-threshold lowering drugs
  • Psychiatric reactions: Hallucinations, confusion
  • Hypoglycaemia
  • Hyponatraemia

Dependence and Tolerance: Repeated use can lead to physical dependence and tolerance, requiring dose escalation for same analgesic effect.

Drug Interactions

All opioids interact with CNS depressants - risk of potentiated respiratory depression and sedation.

General Opioid Interactions

Tramadol-Specific Interactions

Drug Class Interaction Effect
SSRIs & SNRIs Increased risk of seizures and serotonin syndrome
Tricyclic antidepressants Increased seizure risk
Carbamazepine Reduces serum tramadol levels
Warfarin Increased anticoagulant effects

Overdose Management

Opioid Overdose Triad

  • Coma - depressed consciousness
  • Respiratory depression - shallow/absent breathing
  • Pinpoint pupils (miosis) - characteristic finding

Management Protocol

Emergency Treatment
  1. ABCDE approach - Airway, Breathing, Circulation
  2. Naloxone - specific opioid receptor antagonist
  3. Supportive care - ventilation if needed
  4. Monitoring - recurrent respiratory depression possible

Naloxone Notes: Short half-life may require repeated dosing. Monitor for re-sedation after initial reversal.